NCT05491850

Brief Summary

This study determines the effects of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes. Most of the literature shows the impact of physical activity to manage/controlling diabetes. Some studies were conducted on animals to study the impact of physical activity on diabetic neuropathy and neurogenesis. There is no study on the impact of physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans. This study finds the impact of moderate physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 31, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 8, 2022

Completed
Last Updated

August 8, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

July 31, 2022

Last Update Submit

August 4, 2022

Conditions

Keywords

Type 2 diabetes mellitus, moderate physical activity, HbA1c, diabetic neuropathy

Outcome Measures

Primary Outcomes (1)

  • Effect of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes

    Research Hypothesis

    2 Months

Study Arms (2)

Moderate Physical Activity Group

EXPERIMENTAL

The Experimental Group gets moderate physical activity. Elliptical will be performed at least 5 days/per week. Moderate intensity, corresponding approximately to 40-60% of Vo2max (maximal aerobic capacity) 150 min/week of exercise undertaken at moderate intensity or greater. Warm-up and Dynamic stretching is given before and static stretching is given after moderate physical activity.

Other: Moderate Physical Activity for Peripheral Diabetic Neuropathy

Non Specific Physical Activity Group

NO INTERVENTION

The Control group continues their regular medication for diabetic neuropathy.

Interventions

Moderate physical activity can increase movement and heart rate are particularly important for people suffering with peripheral neuropathy. Physical activity can improve blood circulation, which strengthens nerve tissues by increasing the flow of oxygen.

Moderate Physical Activity Group

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Type-II Diabetes
  • Diagnosed cases of Peripheral Diabetic Neuropathy
  • Peripheral Diabetic Neuropathy Stage 1 \& 2
  • Numbness or reduced ability to feel pain or temperature changes.
  • Tingling or burning sensation.
  • Sharp pains or cramps.
  • Increased sensitivity to touch
  • Males and females
  • Age: 35-65
  • HbA1c above 6.5
  • Mild activity level on IPAQ-7 (\< 150min/per week)
  • Berg Balance Scale score (\< 45)

You may not qualify if:

  • Cardiac Issues
  • Any neurological issue
  • Lower limb deformity
  • Acute injury
  • Hip and Knee OA
  • Patients with walking difficulty
  • Diabetic foot

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

RHS Rehabilitation Center

Islamabad, Federal, 46000, Pakistan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetic Neuropathies

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes Complications

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 31, 2022

First Posted

August 8, 2022

Study Start

October 1, 2021

Primary Completion

November 30, 2021

Study Completion

December 25, 2021

Last Updated

August 8, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations